We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

70 hedge funds and large institutions have $354M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

219% more call options, than puts

Call options by funds: $9.35M | Put options by funds: $2.93M

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

25% more funds holding

Funds holding: 56 → 70 (+14)

19% more capital invested

Capital invested by funds: $297M → $354M (+$57M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

Holders
70
Holders Change
+14
Holders Change %
+25%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
18
Reduced
18
Closed
10
Calls
$9.35M
Puts
$2.93M
Net Calls
+$6.42M
Net Calls Change
+$9.19M

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$7.8M
2
NC
Nexthera Capital
New York
+$7.13M
3
O
OppenheimerFunds
New York
+$7.08M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.95M
5
CLCM
Crawford Lake Capital Management
New Jersey
+$4.75M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$15.8M
2
ACA
Avoro Capital Advisors
New York
-$11.6M
3
GTC
Ghost Tree Capital
New York
-$7.33M
4
ACP
Acuta Capital Partners
California
-$5.35M
5
SFM
Sphera Funds Management
Israel
-$3.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Scopia Capital Management
New York
$116M – – –
RG
2
Redmile Group
California
$24.5M -$15.8M -636,515 -41%
MMH
3
Menora Mivtachim Holdings
Israel
$18.1M +$2.57M +103,582 +18%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$17.9M +$2.48M +100,000 +17%
Franklin Resources
5
Franklin Resources
California
$16.9M +$3.37M +136,000 +27%
ACA
6
Avoro Capital Advisors
New York
$15.7M -$11.6M -466,303 -44%
BBA
7
Baker Bros. Advisors
New York
$15.2M – – –
SAM
8
Sectoral Asset Management
Quebec, Canada
$13M +$1.2M +48,468 +11%
ACP
9
Acuta Capital Partners
California
$11.9M -$5.35M -215,944 -32%
SAM
10
Senzar Asset Management
New York
$8.59M +$3.39M +136,900 +73%
GPP
11
Great Point Partners
Connecticut
$8.36M +$7.8M +314,724 New
NC
12
Nexthera Capital
New York
$7.65M +$7.13M +288,000 New
O
13
OppenheimerFunds
New York
$7.59M +$7.08M +285,792 New
Millennium Management
14
Millennium Management
New York
$7.02M -$3.86M -155,728 -37%
ACH
15
ArrowMark Colorado Holdings
Colorado
$7.02M -$1.32M -53,115 -17%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$5.31M +$4.95M +200,000 New
CLCM
17
Crawford Lake Capital Management
New Jersey
$5.09M +$4.75M +191,676 New
BlackRock
18
BlackRock
New York
$3.97M +$3.7M +149,177 +49,726%
Citadel Advisors
19
Citadel Advisors
Florida
$3.31M +$3.09M +124,575 New
OM
20
Opaleye Management
Massachusetts
$3.19M +$124K +5,000 +4%
B
21
Bailard
California
$2.89M +$235K +9,500 +10%
IBT
22
International Biotechnology Trust
United Kingdom
$2.87M +$1.07M +43,248 +67%
PVI
23
Pura Vida Investments
New York
$2.76M +$586K +23,667 +30%
RSCM
24
Rock Springs Capital Management
Maryland
$2.23M +$2.08M +84,079 New
EI
25
EAM Investors
California
$2.17M – – –
1
2 3 4

NDRM Hedge Fund Activity: Q1 2017 in Review

70 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q1 2017, worth a combined $354M — up 19% from $297M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new NDRM positions and 10 closed out — a net gain of 17 holders — while 18 added to existing stakes and 18 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $7.8M. The largest seller was Redmile Group, cutting an estimated $15.8M.

  • 70 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q1 2017, up from 56 in Q4 2016.
  • Funds reported $354M of NeuroDerm Ltd. Ordinary Shares stock for Q1 2017, up 19% quarter-over-quarter.
  • 27 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q1 2017 and 10 closed out, a net change of +17 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q1 2017 was Great Point Partners, an estimated $7.8M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q1 2017 was Redmile Group, an estimated $15.8M sold.

Based on aggregated 13F filings for Q1 2017.